Meeting
2020 ASCO Virtual Scientific Program
Effect of genetic testing results on patient-reported quality of life among patients undergoing panel testing for newly diagnosed ovarian cancer.
Authors
Sarah S. Lee
New York University School of Medicine, New York, NY
Sarah S. Lee , Melissa Kristen Frey , Deanna Gerber , Zachary Phillip Schwartz , Jessica Martineau , Kathleen Lutz , Erin Reese , Emily Dalton , Anne Olsen , Julia Girdler , Bhavana Pothuri , Leslie R. Boyd , John Patrick Curtin , Douglas A. Levine , Stephanie V. Blank
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Cancer Prevention, Risk Reduction, and Genetics
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Germline Genetic Testing
Citation
J Clin Oncol 38: 2020 (suppl; abstr 1584)
DOI
10.1200/JCO.2020.38.15_suppl.1584
Abstract #
1584
Poster Bd #
76
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Uncertainty and coping in patients with newly diagnosed indolent non-Hodgkin’s lymphoma (iNHL).
First Author: Richard Newcomb
Poster
2020 ASCO Virtual Scientific Program
Financial toxicity and patient-reported outcomes over time: A longitudinal study of women with recurrent ovarian cancer.
First Author: Larissa Meyer
Poster
2012 ASCO Annual Meeting
Longitudinal study of hope, meaning/peace (M/P), and quality of life (QOL) in patients (pts) with ovarian cancer (OC).
First Author: Lois M. Ramondetta
Poster
2024 ASCO Annual Meeting
Relationship between cognitive and emotional domains of prognostic awareness with quality of life and psychological distress in patients with advanced cancer.
First Author: Claire Greydanus